| Thursday, September 2, 2010 |
 |
FDA posts new quarterly list from AERS
SILVER SPRING, Md. (Aug. 30) The Food and Drug Administration has posted a new list of drugs from its Adverse Event Reporting System, designed to address potential signals of serious risks and new safety information about drugs on the market.
| |  |
|
 |
|
FDA approves Amneal generic for treatment of hypertension and liver cirrhosis
HAUPPAUGE, N.Y. (Aug. 27) The Food and Drug Administration has approved a generic treatment for hypertension and liver cirrhosis made by Amneal Pharmaceuticals, Amneal said Thursday.
| | |
|
|
|
FDA approves single-pill combination of Novartis drugs for high blood pressure
EAST HANOVER, N.J. (Aug. 27) The Food and Drug Administration has approved a single-pill combination of two drugs made by Novartis for treating high blood pressure, the Swiss drug maker said Friday.
| | |
|
|
|
Research finds risk of developing Type 2 diabetes lower in breast-feeding mothers
PITTSBURGH (Aug. 27) Researchers at the University of Pittsburgh found that mothers who did not breast-feed their children have higher rates of Type 2 diabetes later in life compared with those who breast-fed.
| | |
|
|
|
Type 2 diabetes may have links to Alzheimer’s, study reveals
NEW YORK (Aug. 27) Those with Type 2 diabetes may be at greater risk of developing the brain plaques associated with Alzheimer’s disease, new research suggested.
| | |
|
|
|
FDA gives Sanofi Pasteur the OK to expand use of Menactra vaccine
SWIFTWATER, Pa. (Aug. 26) The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the use of a vaccine in children.
| | |
|
|
|
GlaxoSmithKline introduces ‘Nicorette Makes Quitting Suck Less’ ad campaign
PITTSBURGH (Aug. 26) To help raise awareness around Commit Lozenge, which has been folded into the Nicorette franchise, GlaxoSmithKline earlier this week introduced a new commercial to its “Nicorette Makes Quitting Suck Less” campaign, the company announced Wednesday.
| | |
|
|
|
Medicare coverage of evidence-based tobacco-cessation counseling expanded
WASHINGTON (Aug. 26) The Department of Health and Human Services on Wednesday expanded Medicare coverage of evidence-based tobacco-cessation counseling, removing a barrier to treatment for all tobacco users covered by Medicare, the Centers for Medicare and Medicaid Services announced.
| | |
|
|
|
Teva launches generic version of popular antidepressant
NORTH WALES, Pa. (Aug. 26) Teva Pharmaceutical Industries has launched a generic version of a weekly formulation of a popular antidepressant, the generic drug maker said.
| | |
|
|
|
Hyland’s introduces two homeopathic kids’ remedies for cough-cold/allergy season
WESTLAKE, Ohio (Aug. 25) Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two new products from homeopathic-medicine provider Hyland’s: Nighttime Cold ’n Cough 4 Kids and Complete Allergy 4 Kids.
| | |
|
|
|
Nutramax launches dietary supplement for liver health
EDGEWOOD, Md. (Aug. 24) Nutramax Labs on Monday launched its Samsyl dietary supplement for liver health. Samsyl contains a blend of S-adenosylmethionine, or SAMe, along with a highly bioavailable silybin-soy phosphatidylcholine complex.
| | |
|
|
|
Drug ads linking disease risk with family history influence medication choice
PHILADELPHIA (Aug. 24) Drug advertisements that tie disease risks with family history can influence consumers' choice of medications and have a beneficial effect on those consumers' lifestyle choices, according to a study published in the August issue of the Journal of Applied Communication Research.
| | |
|
|
|
Gallup: Take Care Clinics top in customer service
CONSHOHOCKEN, Pa. (Aug. 24) The results are in, and Take Care Health Systems has good reason to celebrate. Recent Gallup research on customers and customer engagement found that Take Care Clinics rank among the top 10% of all organizations globally in engaging their customers.
| | |
|
|
 |
